Catalogue number 447213, listed by BD Kiestra B.V., Netherlands, under Device, Microtiter Diluting/Dispensing. 3 manufacturers in China are registered for this product code.
Who Else Makes It
Concentrated in Shandong (1), Shanghai (1), Guangdong (1). One is registered as a contract manufacturer, able to build to a specification.
Record
Regulatory record for BD Kiestra™ InoqulA+™ TLA | Listed by | BD Kiestra B.V., Netherlands |
| FDA product code | JTC |
| Device type | Device, Microtiter Diluting/Dispensing |
| Device class | Class 1 |
| Regulation | 21 CFR 866.2500 |
| Establishment | Specification developer, Manufacturer |
| Premarket notification | Exempt |
| Record published | 2018-05-25 |
| Record revised | 2025-08-04 (version 6) |
Specifications
Specifications | MRI safety | Labeling does not contain MRI Safety Information |
| Prescription | Prescription only |
| Label carries | manufacturing date, serial number |
| Storage | Storage environment temperature 18 to 27 °C |
Recalls Naming This Product
1 recall names this product by its own identifier, the UDI on its label.
Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.